Creating digital models of the spleen to improve treatments for sickle cell disease
Digital twins of the spleen to accelerate the design and development of new therapies in sickle cell disease
This study is creating digital models of the spleen to help us understand and improve treatments for sickle cell disease, aiming to find better ways to help both kids and adults manage their symptoms and reduce the need for surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11049319 on NIH RePORTER |
What this research studies
This research focuses on developing digital twins of the spleen to better understand and treat sickle cell disease (SCD). By simulating how the spleen functions in clearing altered red blood cells, the research aims to identify ways to enhance the spleen's ability to manage sickle cell complications. The approach includes advanced modeling techniques and clinical assessments to explore how improving red blood cell deformability can reduce the need for splenectomy and improve patient outcomes. This innovative methodology seeks to provide insights that could lead to new therapies for both children and adults suffering from SCD.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adults diagnosed with sickle cell disease, particularly those experiencing complications related to spleen function.
Not a fit: Patients with sickle cell disease who have already undergone splenectomy or those with advanced complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management of sickle cell disease, reducing complications and enhancing the quality of life for patients.
How similar studies have performed: While the approach of using digital twins is relatively novel, similar research has shown promise in improving treatment strategies for other conditions.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Karniadakis, George — Brown University
- Study coordinator: Karniadakis, George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.